| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Melittin inhibits vascular smooth muscle cell proliferation through induction of apoptosis via suppression of nuclear factor-kappaB and Akt activation and enhancement of apoptotic protein expression.
|
J Pharmacol Exp Ther
|
2006
|
0.98
|
|
2
|
Higher biofilm formation in multidrug-resistant clinical isolates of Staphylococcus aureus.
|
Int J Antimicrob Agents
|
2008
|
0.98
|
|
3
|
Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity.
|
Atherosclerosis
|
2006
|
0.90
|
|
4
|
Luteolin prevents PDGF-BB-induced proliferation of vascular smooth muscle cells by inhibition of PDGF beta-receptor phosphorylation.
|
Biochem Pharmacol
|
2005
|
0.88
|
|
5
|
Antithrombotic and antiplatelet activities of fenofibrate, a lipid-lowering drug.
|
Atherosclerosis
|
2009
|
0.86
|
|
6
|
Inhibitory effect of fenofibrate on neointima hyperplasia via G(0)/G(1) arrest of cell proliferation.
|
Eur J Pharmacol
|
2010
|
0.86
|
|
7
|
Pterostilbene, a natural dimethylated analog of resveratrol, inhibits rat aortic vascular smooth muscle cell proliferation by blocking Akt-dependent pathway.
|
Vascul Pharmacol
|
2010
|
0.86
|
|
8
|
Sulforaphane inhibits PDGF-induced proliferation of rat aortic vascular smooth muscle cell by up-regulation of p53 leading to G1/S cell cycle arrest.
|
Vascul Pharmacol
|
2013
|
0.86
|
|
9
|
Myriocin, a serine palmitoyltransferase inhibitor, suppresses tumor growth in a murine melanoma model by inhibiting de novo sphingolipid synthesis.
|
Cancer Biol Ther
|
2012
|
0.84
|
|
10
|
Antiplatelet and antithrombotic activities of Korean Red Ginseng.
|
Arch Pharm Res
|
2006
|
0.83
|
|
11
|
Clitocybin A, a novel isoindolinone, from the mushroom Clitocybe aurantiaca, inhibits cell proliferation through G1 phase arrest by regulating the PI3K/Akt cascade in vascular smooth muscle cells.
|
J Pharmacol Sci
|
2012
|
0.83
|
|
12
|
Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity.
|
J Cardiovasc Pharmacol
|
2008
|
0.82
|
|
13
|
Inhibitory effects of Tabebuia impetiginosa inner bark extract on platelet aggregation and vascular smooth muscle cell proliferation through suppressions of arachidonic acid liberation and ERK1/2 MAPK activation.
|
J Ethnopharmacol
|
2006
|
0.82
|
|
14
|
Hesperetin, a bioflavonoid, inhibits rat aortic vascular smooth muscle cells proliferation by arresting cell cycle.
|
J Cell Biochem
|
2008
|
0.80
|
|
15
|
Oleanolic acid, a pentacyclic triterpenoid, induces rabbit platelet aggregation through a phospholipase C-calcium dependent signaling pathway.
|
Arch Pharm Res
|
2007
|
0.80
|
|
16
|
Growth and siderophore production of staphylococci in human peritoneal dialysate.
|
J Korean Med Sci
|
2003
|
0.80
|
|
17
|
Ceramide 1-phosphate induces neointimal formation via cell proliferation and cell cycle progression upstream of ERK1/2 in vascular smooth muscle cells.
|
Exp Cell Res
|
2011
|
0.79
|
|
18
|
Epothilone D, a microtubule-stabilizing compound, inhibits neointimal hyperplasia after rat carotid artery injury by cell cycle arrest via regulation of G1-checkpoint proteins.
|
Vascul Pharmacol
|
2007
|
0.79
|
|
19
|
Genistein inhibits rat aortic smooth muscle cell proliferation through the induction of p27kip1.
|
J Pharmacol Sci
|
2008
|
0.78
|
|
20
|
Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
|
Vascul Pharmacol
|
2006
|
0.78
|
|
21
|
Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization.
|
J Pharmacol Exp Ther
|
2004
|
0.78
|
|
22
|
Inhibitory effects of docetaxel on platelet-derived growth factor (PDGF)-BB-induced proliferation of vascular smooth muscle cells through blocking PDGF-receptor β phosphorylation.
|
J Pharmacol Sci
|
2011
|
0.77
|
|
23
|
An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
|
Basic Clin Pharmacol Toxicol
|
2005
|
0.77
|
|
24
|
Anti-platelet activity of KR-32560, a novel sodium/hydrogen exchanger-1 inhibitor.
|
Pharmacol Res
|
2006
|
0.77
|
|
25
|
Inhibition of PDGF beta-receptor tyrosine phosphorylation and its downstream intracellular signal transduction in rat aortic vascular smooth muscle cells by kaempferol.
|
Planta Med
|
2005
|
0.77
|
|
26
|
Antiplatelet activity of obovatol, a biphenolic component of Magnolia Obovata, in rat arterial thrombosis and rabbit platelet aggregation.
|
J Atheroscler Thromb
|
2011
|
0.77
|
|
27
|
Effect of Ginkgo biloba extract on endotoxin-induced labyrinthitis.
|
Int J Pediatr Otorhinolaryngol
|
2011
|
0.77
|
|
28
|
Antiproliferative action of cudraflavone B, isolated from Cudrania tricuspidata, through the downregulation of pRb phosphorylation in aortic smooth muscle cell proliferation signaling.
|
J Cardiovasc Pharmacol
|
2009
|
0.76
|
|
29
|
Antiplatelet effect of NQ12: a possible mechanism through the arachidonic acid cascade.
|
J Pharmacol Sci
|
2007
|
0.75
|
|
30
|
The N3 subdomain in a domain of fibronectin-binding protein B isotype I is an independent risk determinant predictive for biofilm formation of Staphylococcus aureus clinical isolates.
|
J Microbiol
|
2013
|
0.75
|
|
31
|
Clitocybin B inhibits rat aortic smooth muscle cell proliferation through suppressing PDGF-Rβ phosphorylation.
|
Vascul Pharmacol
|
2011
|
0.75
|
|
32
|
Development of a bottle-free multipurpose incubator for generating various bacterial culture conditions.
|
J Microbiol
|
2005
|
0.75
|